SCHEMBL3849915

SCHEMBL3849915

CCOC(=O)c1cccc(N2CCN(CCC3CCN(C(=O)O)CC3)CC2)c1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.49
DRD2 P14416 3/20 0.48
DRD3 P35462 3/20 0.48
HTR1A P08908 1/20 0.48
HTR2A P28223 1/20 0.48
ALDH1A1 P00352 2/20 0.47
TSHR P16473 1/20 0.47
LMNA P02545 2/20 0.46
MAPK1 P28482 3/20 0.46
ATM Q13315 1/20 0.46
HTR7 P34969 1/20 0.46
NPY2R P49146 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ALOX5 P09917 1/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4505636 0.89 GPR119 (0.56) MAPTDRD2DRD3HTR1AHTR2A
SCHEMBL4509537 0.88 ALDH1A1 (0.53) MAPTDRD2DRD3HTR1AHTR2A
SCHEMBL3844622 0.87 DRD2 (0.49) DRD2DRD3HTR2AHTR7
SCHEMBL27752805 0.85 MAPT (0.44) MAPTDRD2DRD3HTR1AHTR2A
SCHEMBL6011450 0.85 ALDH1A1 (0.56) MAPTALDH1A1TSHRLMNAMAPK1
SCHEMBL3843639 0.83 SMN1; SMN2 (0.48) MAPTDRD2DRD3ALDH1A1TSHR
SCHEMBL3845966 0.82 DRD2 (0.46) DRD2DRD3HTR7
SCHEMBL3845963 0.82 DRD4 (0.51) MAPTDRD2DRD3HTR7
SCHEMBL6420684 0.81 ALOX5 (0.52) MAPTDRD2ALDH1A1TSHRLMNA
SCHEMBL3849039 0.78 DRD2 (0.49) DRD2DRD3HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038268-A2 CARBONYLATED (AZA)CYCLOHEXANES AS DOPAMINE D3 RECEPTOR LIGANDS BIOPROJET (FR) 2009-03-25 EP disclosed
WO-2007148208-A2 CARBONYLATED (AZA) CYCLOHEXANES AS DOPAMINE D3 RECEPTOR LIGANDS BIOPROJET (FR) 2007-12-27 WO disclosed